COVID-19 Vaccine Statement
Pacific Urology provides patients with COVID-19 vaccine recommendations and information.
Pacific Urology provides patients with COVID-19 vaccine recommendations and information.
Dr. Paraminder Sethi shares his experience with benign prostatic hyperplasia (BPH) and the Rezūm therapy that helped him.
Our founder Dr. Stephen Taylor says goodbye in a letter after 40 years of leading a state-of-the-art practice, leaving patients in good hands.
Pacific Urology is participating in a clinical trial for a new medical device treatment for patients with drug-resistant overactive bladder.
Dr. Parminder Sethi of Pacific Urology is recognized as an expert in treating benign prostatic hyperplasia (BPH), or enlarged prostate, with Rezūm®, a safe and effective minimally invasive treatment option for men suffering from BPH that provides an alternative to a lifetime of taking medications.
Dr. Sethi of Pacific Urology is one of the first Bay Area physicians trained in the Rezūm System, an innovative minimally invasive treatment option for men with benign prostatic hyperplasia (BPH).
Dr. Wei Zheng is featured in the June edition of the John Muir Health Physician Newsletter. Read his interview on kidney stone treatment and how to prevent them.
A new proposal by the U.S. Preventive Services Task Force is relaxing its controversial opposition to prostate-specific antigen (PSA) testing for men. PSA tests aid in the early detection of prostate cancer.
Pacific Urology is pleased to announce that Dr. Parminder Sethi has been selected by Castle Connolly as “America’s Top Doctors” for 2017. The notable recognition was recently featured in San Francisco Magazine.
Dr. Jeremy Lieb details the importance of new prostate cancer tests in a CNBC article.